Pharmacovigilance Analysis of Serious Adverse Events Reported for Biologic Response Modifiers Used as Prophylaxis against Transplant Rejection: a Real-World Postmarketing Experience from the US FDA Adverse Event Reporting System (FAERS)

Podobne knjige/članki

• Rhabdomyolysis Associations with Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS)
  od: Teng, Chengwen, et al.
  Izdano: (2019)
• Pericardial Toxicities Associated With Immune Checkpoint Inhibitors: A Pharmacovigilance Analysis of the FDA Adverse Event Reporting System (FAERS) Database
  od: Ma, Zhuo, et al.
  Izdano: (2021)
• Exploring the FDA Adverse Event Reporting System (FAERS) to Generate Hypotheses for Disease Monitoring
  od: Fang, Hong, et al.
  Izdano: (2014)
• Disproportionality Analysis of Safety with Nafcillin and Oxacillin with the FDA Adverse Event Reporting System (FAERS)
  od: Timbrook, Tristan T., et al.
  Izdano: (2020)
• Cardiovascular Safety Profile of Romosozumab: A Pharmacovigilance Analysis of the US Food and Drug Administration Adverse Event Reporting System (FAERS)
  od: Vestergaard Kvist, Annika, et al.
  Izdano: (2021)